NCT06413524 The Effects of Different Vibration Exercises on COPD Patients
| NCT ID | NCT06413524 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Medical University |
| Condition | COPD |
| Study Type | INTERVENTIONAL |
| Enrollment | 18 participants |
| Start Date | 2024-08-08 |
| Primary Completion | 2025-04-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 18 participants in total. It began in 2024-08-08 with a primary completion date of 2025-04-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pulmonary rehabilitation is effective in improving exercise tolerance, dyspnea, and fatigue in patients with COPD, and exercise training is an important component of pulmonary rehabilitation. Vibration training can be used as a supplement or alternative to traditional exercise and is a short, safe rehabilitation training. COPD patients will be recruited and randomly assigned to the control group, whole-body vibration training group, or local vibration training group. The study aims to confirm the rehabilitative benefits of enhancing lower limb muscle strength, exercise endurance, and the quality of life related to COPD in patients.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 40. 2. Diagnosis of chronic obstructive pulmonary disease (COPD) based on the criteria established by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). 3. Disease Severity: FEV1 \< 50% or COPD patients who have used systemic corticosteroids due to an acute exacerbation of COPD within the past year and are currently in a stable condition. 4. Willingness to participate in vibration exercise intervention and ability to comply with the study activities, including signing the informed consent form. 5. Clear consciousness, normal cognitive function, and ability to communicate in Mandarin or Taiwanese for understanding experimental procedures and relevant instructions. Exclusion Criteria: 1. Engages in regular physical activity, exercising at least 3 times a week for over 30 minutes, with a Borg Scale rating of 3 for breathlessness after exercise. 2. The interval since the last pulmonary rehabilitation is less than three months. 3. Contraindications to vibration therapy: pregnancy, cardiovascular diseases (with a pacemaker or stent), intervertebral disc diseases, tendinitis, arthritis, hernia, presence of tumors, orthopedic or trauma-related conditions, epilepsy, history of deep vein thrombosis, patients with internal implants. 4. Inability to undergo training or walk due to physical factors, such as being bedridden for an extended period, relying on a ventilator for an extended period, prone to dizziness, central nervous system disorders, etc. 5. Underwent lower limb-related surgery within the past year or is in the recovery period post-surgery. 6. Currently diagnosed with cancer or undergoing cancer treatment. 7. Participation in other research studies.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06413524 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 99 Years, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06413524 currently recruiting?
Yes, NCT06413524 is actively recruiting participants. Contact the research team at gracelin@tmu.edu.tw for enrollment information.
Where is the NCT06413524 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06413524 clinical trial?
NCT06413524 is sponsored by Taipei Medical University. The trial plans to enroll 18 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.